$40 – $55

Financing Strategy: From Creation to Exit

Event Information

Share this event

Date and Time

Location

Location

Meeting Venue Provided by DeviceTalks2017

@ Westin Boston Waterfront

425 Summer St

Boston, Massachusetts 02210

View Map

Friends Who Are Going
Event description

Description

NEW ENGLAND HEALTHCARE EXECUTIVE MEETING

OCTOBER 2, 2017, 7:30AM TO 10:00AM

FINANCING STRATEGY FROM CREATION TO EXIT

INVESTORS, INFLECTION POINTS AND YOUR BUSINESS PLAN


Our meeting space is being provided by DeviceTalks 2017

DeviceTalks 2017

Westin Boston Waterfront | 425 Summer St | Boston, MA 02210

For Driving and Parking Information, click here.



NOTE: This month's meeting is in concurrence with DeviceTalks Boston 2017. Following the meeting, participants are invited to the DeviceTalks Exhibition and Networking Break at 10am.

Discount registration to DeviceTalks is available using Promotional Code “NEHEN”.



Program Description:

From their founding through concept validation, growth to scale and exit or IPO, companies and their leadership team face complex and evolving financing challenges. Design and execution of successful financing strategies at each stage of a company’s life cycle will be addressed by our deeply experienced panelists and keynote speaker. Companies must match their financing strategy to their development stage and opportunities for major changes in valuation. As the company profile changes over time, the type of investor open to considering the company will also change. To be successful as a business and to successfully raise the capital needed for growth, the leadership team must develop a business model and business plan founded on a realistic long term financing strategy. How to do that is the subject of this program.

Keynote Speaker:

Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

Dennis is the author of The Peddler’s Prerogative and The Life Science Executive’s Fundraising Manifesto.

Moderator:

Rick Williams, Partner, Newport Board Group

Rick is a CEO and board advisor. Nationally published thought leader on preparing to raise capital, overcoming barriers to growth and preparing for the sale of the company.

Panelists:

- Richard Anders, Founder Managing Director, MA2 (Massachusetts Medical Angels)

Richard is an investor and long-time entrepreneur. He teaches medical device entrepreneurship at the Harvard/MIT HST program.

- Bill Edelman, Serial entrepreneur

Bill is a medical device industry executive with over 37 years’ experience and currently serves as Chairman of the Board for a number of development stage companies.

- Steve Gullans, Ph.D., Managing Director, Excel Venture Management

Steve Gullans, Ph.D., is an author, scientist, entrepreneur, and biotech investor in life science companies with transformative technologies.

Join this future focused, visionary, and engaging blue ribbon panel of experts. Ask questions. Contribute your insights during the audience interactive segment.

Topics for discussion:

  • How do you analyze and present your technology, team, and requirements?
  • What are the various stages of the business and how might team requirements change?
  • What investment vehicles should be considered depending on the business stage?
  • What elements drive enterprise value and ability to attract capital?
  • What are the strategies and opportunities for finding sources of capital?
  • Why should the entrepreneur seek to find the “right fit” and not just any investor?

Who should attend? CEOs, CMOs, CTOs, CFOs, clinicians, technologists, investors, and business experts seeking a better understanding of capital raises, or looking to improve performance on their next round.

Speaker Biographies:

Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series
Dennis Ford is an entrepreneur and author with expertise in sales, marketing, and business development. He has spent most of his career launching new companies. Over the last decade, he has worked extensively with global alternative investors interested in high-growth early-stage technologies. His expertise encompasses using database subscription services to create business solutions and using the Internet to create an interactive dialog between buyers and sellers. He is a big proponent of using profiling and matching technology to find that all-important business fit in the marketing and selling process. Before LSN, Dennis was the President and CEO of Brighton House Associates (BHA). BHA was launched in order to improve the way hedge fund and private equity fund managers raised capital and marketed their funds to investors.

Ford is the author of The Peddler’s Prerogative and The Life Science Executive’s Fundraising Manifesto, two well-received sales and marketing books.

Richard Anders, Founder Managing Director,, MA2 (Massachusetts Medical Angels)
Richard Anders is an investor and long-time entrepreneur. He founded the legal software publishing company Jurisoft, which he sold to Lexis/Nexis, published newspapers including Boston Digital Industry and New York Digital Industry and currently serves as managing director of Rubin/Anders Scientific, which places scientists as consultants in patent projects. He has invested in approximately two dozen early-stage startups.

Anders is a long-time trustee of the Museum of Science in Boston, where he is a member of the food committee, exploring science education around the issues of food and its preparation, a trustee of the Forsyth Institute and an overseer at the Brigham & Women’s Hospital and the Gardner Museum. Anders founded and currently runs MA Medical Angels (MA2), one of the country's leading angel groups focused exclusively on life sciences. He has founded the angel group Launchpad, the nationally renowned Science on Screen event at the Coolidge Corner Cinema and was a founding trustee of the Massachusetts Interactive Media Council. He served for many years as a member of the Dana Farber Cancer Center Institutional Review Board. He is Industry Champion for Life Sciences at MassChallenge, a board observer at Siamab Therapeutics and serves on the Coulter grant committee at Boston University and the SPARK grant committee at UVM. Anders teaches medical device entrepreneurship at the Harvard/MIT HST program. He is a graduate Summa Cum Laude in Mathematics from Harvard and holds a J.D. from Harvard Law School.

Bill Edelman, Serial entrepreneur
Bill Edelman, is a medical device industry executive with over 37 year’s experience and currently serves as Chairman of the Board for Highland Instruments, Inc., (neurostimulation), Paragonix Technologies, Inc., (organ transport systems), and Corsens (cardiac monitoring). Mr. Edelman also serves as a Board Member for MindChild Medical, Inc., (non-invasive fetal monitoring). Mr Edelman serves as a member of the Advisory Council for the Department of Biomedical Engineering at Rensselaer Polytechnic Institute (Troy, NY).

Mr. Edelman previously served as CEO for ETView, Ltd., (TASE: ETVW) (airway management) acquired by Ambu A/S(CPH:AMBU-B) September 2016, member of the Screening Committee for Medical Devices for Mass Medical Angels, Chairman of the Board for Vitathreads LLC, (aesthetics wound repair), NewVert, Ltd., (spinal implants), Flexicath, Ltd., (IV catheterization), PolyTouch, Ltd., (general surgical instrumentation) (acquired by Covidien in 2011), Stimatix GI, Ltd., (ostomy products), Medivalve, Ltd., (percutaneous aortic valve placement), Cardioflow, Ltd., (embolic protection) and Leviticus Cardio, Ltd., (cardiac assist power systems), Advisor on the Heathcare Board, for Northeast Securities, Inc., and Advisor to First Light Bioscienses, Inc. (automated medical diagnostic products).

Previously, Mr Edelman served as President & Chief Executive Officer, TYRX, Inc., a commercial stage venture backed medical device company focused in drug/device implant products for general surgery, electrophysiology and cosmetic surgery. TYRX was acquired by Medtronic, Inc., in 2014.

Prior to TYRX, Mr. Edelman held executive level positions at MicroSense International, LLC (bio-sensing) acquired by Becton, Dickinson and Company (BDX), FibraSonics, Inc. (ultrasonic surgical products) acquired by Misonix, Inc. (MSON), NeuroMod, Inc. (neuro-stimulation technologies), St. Jude Medical, Inc., Pfizer, Inc., and Baxter International, Inc.

Steve Gullans, Ph.D., Managing Director, Excel Venture Management
Steve Gullans, Ph.D., is an author, scientist, entrepreneur, and biotech investor. He is a Managing Director at Excel Venture Management where he invests in life science companies with transformative technologies. Previously Steve co-founded and held senior executive roles at biotech companies. Currently, he is a Director at Cleveland HeartLab, Gemphire [GEMP], NofOne, and Orionis Biosciences and he previously was a Director at Molecular Templates [MTEM],Tetraphase Pharmaceuticals [TTPH] and other successful startups.
Steve loves innovation and has spoken widely, including at TED and TEDx. He and Juan Enriquez recently co-authored Evolving Ourselves, a book that provides a sweeping tour of how humans are changing the course of evolution—sometimes intentionally, sometimes not. Previously he was a professor at Harvard Medical School where he published more than 130 scientific papers and was elected Fellow of the American Association for the Advancement of Science. Steve lives in Boston where he enjoys working with young entrepreneurs, playing golf and tennis, and teaching his granddaughter to say, “We want ice cream sandwiches for lunch.”

Rick Williams, Partner, Newport Board Group
Rick Williams helps leaders make important decisions. His unique insights are most valuable at critical junctures – creating a viable business model, preparing to raise capital, working to overcome barriers to growth or preparing for sale of the company. His thought leadership with a CEO and board point of view on how to make companies successful is widely published. Rick is a Partner with the Newport Board Group - a national partnership providing advisory support for senior leaders and boards of middle market companies. Rick was Founder and President of The Equity Company, an award winning multifamily real estate investment and development company. He was a management consultant with the global consulting firm Arthur D. Little, Inc. Rick also was President of the Harvard Business School Association of Boston. His board of director work includes serving as Chairman of the Board of Point Care Technologies, board chair for the quasi-public bank/VC firm now named the Growth Capital Corp, board member of Amorphex Therapeutics and board member of FairWay Financial US.


SPONSORSHIP KINDLY PROVIDED BY:


DeviceTalks 2017









Share with friends

Date and Time

Location

Meeting Venue Provided by DeviceTalks2017

@ Westin Boston Waterfront

425 Summer St

Boston, Massachusetts 02210

View Map

Save This Event

Event Saved